Abstract
We report the result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension. Aim of the study was to evaluate self-reported efficacy and patients’ satisfaction with the medication. Most patients were very satisfied with the medication and chose to continue it.
Similar content being viewed by others
References
Camilleri M, Malagelada JR, Stanghellini V, Fealey RD, Sheps SG (1985) Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology 88(6):1852–1859
Chobadian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D (1979) Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med 301(2):68–73
Consensus statement (1996) The definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 519:1–10
Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y (2003) Association between supine hypertension and orthostatic hypotension in autonomic failure [erratum appears in Hypertension (2003) 43(4):e12]. Hypertension 42(2):136–142
Jacob G, Shannon JR, Black B, et al. (1997) Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 96(2):575–580
Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA (1997) Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group [erratum appears in JAMA (1997) 278(5):388]. JAMA 277(13):1046–1051
Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I, Robertson D, Biaggioni I (1997) The hypertension of autonomic failure and its treatment. Hypertension 30(5):1062–1067
Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA (2003) Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension [see comment]. J Neurol Neurosurg Psychiatry 74(9):1294–1298
Wieling W, van Lieshout JJ (1997) Maintenance of postural normotension in humans. In: Low PA (ed.) Clinical autonomic disorders: evaluation and management. 2nd ed. Philadelphia. Lippincott-Raven, pp 73–82
Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, Low PA (1998) A doubleblind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 51(1):120–124
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported in part from grants from the National Institutes of Health, Bethesda, MD: 5 K23 RR15537 (Dr. Sandroni), NS3 2352, NS4 4233 NS4 3364 (Dr. Low), and Mayo GCRC grant M01-RR00585
Rights and permissions
About this article
Cite this article
Sandroni, P., Opfer-Gehrking, T.L., Singer, W. et al. Pyridostigmine for treatment of neurogenic orthostatic hypertension. Clin Auton Res 15, 51–53 (2005). https://doi.org/10.1007/s10286-005-0225-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10286-005-0225-3